Table 8.
Mature sizea | Implantb | Pooled | |||||
---|---|---|---|---|---|---|---|
Item | SMS | LMS | P value | NI | SS | P value | SEM |
n, steers | 77 | 75 | – | 76 | 76 | – | – |
n, pens | 10 | 10 | – | 10 | 10 | – | – |
HCW, kg | 363 | 414 | <0.01 | 385 | 392 | <0.01 | 1.0 |
Dressc, % | 61.92 | 62.75 | <0.01 | 62.20 | 62.47 | 0.23 | 0.151 |
Back fat thickness, cm | 1.39 | 1.58 | <0.01 | 1.48 | 1.50 | 0.71 | 0.033 |
LMA, cm2 | 83.76 | 89.31 | <0.01 | 86.18 | 86.88 | 0.34 | 0.495 |
LMA/HCW, 6.45 cm2/45.4 kg | 1.62 | 1.53 | <0.01 | 1.59 | 1.56 | 0.07 | 0.008 |
Calculated yield grade | 3.15 | 3.45 | <0.01 | 3.29 | 3.31 | 0.73 | 0.050 |
Marbling scored | 618 | 621 | 0.77 | 623 | 616 | 0.54 | 7.6 |
Kidney pelvic heart fat | 1.95 | 1.87 | <0.01 | 1.92 | 1.90 | 0.22 | 0.013 |
Quality grade | |||||||
Prime, % | 3.88 | 5.22 | 0.69 | 5.21 | 3.89 | 0.70 | 2.438 |
High Choice, % | 13.00 | 12.01 | 0.86 | 10.56 | 14.45 | 0.48 | 3.892 |
Average Choice, % | 40.07 | 36.15 | 0.62 | 41.93 | 34.29 | 0.33 | 5.601 |
Low Choice, % | 39.19 | 38.52 | 0.93 | 34.33 | 43.38 | 0.26 | 5.696 |
Select, % | 3.86 | 8.10 | 0.27 | 7.97 | 3.99 | 0.30 | 2.732 |
EBFe, % | 30.72 | 32.23 | <0.01 | 31.42 | 31.53 | 0.69 | 0.202 |
AFBWe,f, kg | 529 | 581 | <0.01 | 550 | 560 | 0.07 | 3.4 |
EQSBWg, kg | 288 | 316 | <0.01 | – | – | – | 1.7 |
Calculated FSh | 4.82 | 6.48 | <0.01 | 5.52 | 5.78 | 0.05 | 0.085 |
aSMS, smaller mature size; LMS, larger mature size.
bNI, nonimplanted during backgrounding-phase, implanted with 24 mg estradiol and 120 mg trenbolone acetate on d 85; SS, implanted with 20 mg estradiol benzoate and 200 mg progesterone on d 2 and with 24 mg estradiol and 120 mg trenbolone acetate on d 85.
cCalculated as HCW divided by final body weight.
dSmall0, 500, Modest0, 600.
eEstimated using equations of Guiroy et al. (2001).
fAFBW, final shrunk weight at 28% empty body fat.
gEQSBW, equivalent shrunk body weight (Tyultki et al., 1994).
hEstimated using final shrunk weight at 28% EBF and data from Fox et al. (1992).